Market Research Reports, Inc. has announced the addition of “Global Biosimilars/Follow-on-Biologics Market (Technology, Types, Applications, Services and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020” research report to their offering. See more at- http://mrr.cm/Z7X

1. www.MarketResearchReports.com
Category : Pharma & Healthcare
All logos and Images mentioned on this slide belong to their respective owners.

2. www.MarketResearchReports.com
Introduction to Report
 Launch Date: July 1, 2014
 Number of Pages: 184
 Geography Coverage: Global
 Available Format: PDF
Price For Single User License: USD 4,515
Price For Site User License: USD 7,515
Price For Global User License: USD 10,515
Delivery Time: Within 24 Hours (During Working Days)

3. www.MarketResearchReports.com
About the Report
"Global biosimilars/follow-on-biologics market (types,
applications and geography) - Size, Share, Global Trends,
Company Profiles, Demand, Insights, Analysis, Research,
Report, Opportunities, Segmentation and Forecast, 2013 -
2020", suggests that the global biosimilars market would
reach $35 billion by 2020 from the estimated $1.3 billion
in 2013.
Deeper penetration with clearer regulatory pathways in
developed markets and higher efficacy & safety in
emerging markets will back the market growth during the
forecast period.

4. www.MarketResearchReports.com
Research Findings
Global biosimilars/follow-on-biologics market accounted for
$1,358 million in 2013 and it is anticipated to generate $35,032
million by 2020, growing at a CAGR of 60.8% from 2014 to 2020.
Regulations for biosimilars plays a vital role in maintaining the
viability and balance between original and biosimilar products.
Various regulatory authorities, namely EMA and the U.S. FDA are
actively regulating the biosimilars market.
Geographically, Biosimilars market is segmented into North
America, Europe, Asia-Pacific and LAMEA. Due to favorable
regulatory policies designed by the European Medical
Association, the European market has been maximizing on the
biosimilars market.
Europe was the first region to draft guidelines for approval of
biosimilars in 2006. Nevertheless, in 2008, the first biosimilars
version of Granulocyte colony-stimulating factor (G-CSF) was
introduced in the European Union under the regulatory guidance
of European Medical Association (EMA).

5. www.MarketResearchReports.com
Key Benefits
The study is segmented in a strategic divisions to gain
deeper insights into the market dynamics and understand
the competitive environment of the overall market
Financial market forecast is provided for the next eight
years by considering 2013 as the base year
Comprehensive and quantitative data about changing
market trends, intensifying competition and opportunities
in biosimilars market are provided to make better
business decisions

6. www.MarketResearchReports.com
Key Benefits Continues…
Porter’s Five Forces model and SWOT analysis of the
overall market is provided to help stakeholders gain
strategic insights of the market
Deep dive analysis of key market players and strategies
adopted by them are expounded to provide valuable
information on the top contenders in the market
Identification of key investment pockets for the
biosimilars market is strategically dealt to assist the
stakeholders

7. www.MarketResearchReports.com
Segments Covered
Market By Technology
Market By Types
Market By Applications
Market By Services
Market By Geography

8. www.MarketResearchReports.com
Report Coverage
1. Introduction
2. Executive Summary
3. Market Overview
4. Global Biosimilars/Follo-on-biologics Market By
Technology
5. Global Biosimilars/Follow-on-biologics Market By
Product Type
6. Global Biosimilars/Follow-on-biologics Market By
Applications
7. Global Biosimilars / Follow-on-biologics Market By
Services
8. Global Biosimilars/Follow-on-biologics Market By
Geographies
9. Key Products And Recent Activities By Geography
10.Company Profiles
For more details regarding Report coverage see the last slide
All logos and Images mentioned on this slide belong to their respective owners.

9. www.MarketResearchReports.com
Company Coverage
1. Novartis (Sandoz)
2. Synthon Pharmaceuticals, Inc.
3. Teva Pharmaceutical Industries Ltd.
4. LG Life Sciences
5. Celltrion
6. Biocon
7. Hospira
8. Merck Serono (Merck Group)
9. Biogen idec Inc.
10.Genentech (Roche Group).
For more details regarding Report coverage see the last slide
All logos and Images mentioned on this slide belong to their respective owners.

10. www.MarketResearchReports.com
Custom Research:
 Are you an industry professional, entrepreneur,
venture capitalist, investors and organization, then let
us know your specific research requirements. Our goal
is to cater to your requirements be it for a custom
market research project, syndicated research report on
a specific market or industry sector, newsletter creation,
case study development or anything else related to
marketing research.
For Any Customization Related query Visit IdeaCenter @
http://www.marketresearchreports.com/idea-center

11. www.MarketResearchReports.com
How To Buy This Report?
Visit following URL to see Table of Content and
purchase this publication:
http://mrr.cm/Z7X
About Market Research Reports, Inc.
Market Research Reports provides a customized set
of reports from reputed Publishers, built on the
intelligence available within organizations and
leverages on our motto of “Intelligence Redefined”.
Contact : Amitava Sen
Email : info@marketresearchreports.com
Phone: +1 302-703-7787 (USA) +91-8762746600 (India)